DESIGNING DE NOVO PROTEIN IMMUNOTHERAPIES
USING GROUND-BREAKING COMPUTATIONAL METHODS
Neoleukins represent a novel class of drugs that precisely regulate immune pathways as potential treatments for human diseases. Sophisticated technology is used to create new protein sequences that are more potent, stable, and selective than natural or modified proteins. The scientific founders are among the world's leaders in the emerging field of de novo protein design.